Literature DB >> 16417597

Management of spasticity in adults: practical application of botulinum toxin.

M S Pathak1, H T Nguyen, H K Graham, A P Moore.   

Abstract

Spasticity, characterized by increased muscle tone, exaggerated stretch reflexes, and abnormal limb posture, is a common sequel of central nervous system pathology. Historically, medicinal treatments have been of limited efficacy. This review discusses the clinical features of spasticity, the functional and pathological consequences, and treatment. It reviews the most common patterns of spasticity encountered in the upper and lower limbs and focuses on focal treatment of spastic muscles with the three commercially available botulinum toxins Botox, Dysport, and Myobloc/NeuroBloc. It addresses practical details such as muscle selection and identification, drug dilution, and doses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417597     DOI: 10.1111/j.1468-1331.2006.01444.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

Review 1.  Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury.

Authors:  Alexander G Rabchevsky; Patrick H Kitzman
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

2.  Prevalence of neutralising antibodies in patients treated with botulinum toxin type A for spasticity.

Authors:  Kerstin Müller; Eilhard Mix; Fereshte Adib Saberi; Dirk Dressler; Reiner Benecke
Journal:  J Neural Transm (Vienna)       Date:  2009-04-08       Impact factor: 3.575

3.  Ultrasonographic evaluation of needle insertion site for the flexor pollicis longus.

Authors:  Seung Min Lee; Kihoon Kim; Sang Min Lee; Hyun Seok Lee
Journal:  Ann Rehabil Med       Date:  2013-04-30

Review 4.  Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity.

Authors:  R L Rosales; A S Chua-Yap
Journal:  J Neural Transm (Vienna)       Date:  2008-03-06       Impact factor: 3.575

Review 5.  Botulinum toxin in poststroke spasticity.

Authors:  Suheda Ozcakir; Koncuy Sivrioglu
Journal:  Clin Med Res       Date:  2007-06

6.  Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.

Authors:  Y Dionyssiotis; D Kiourtidis; A Karvouni; A Kaliontzoglou; I Kliafas
Journal:  Ther Clin Risk Manag       Date:  2012-10-19       Impact factor: 2.423

7.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

8.  Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study.

Authors:  Gerard E Francisco; Wolfgang H Jost; Ganesh Bavikatte; Daniel S Bandari; Simon F T Tang; Michael C Munin; Joan Largent; Aubrey M Adams; Aleksej Zuzek; Alberto Esquenazi
Journal:  PM R       Date:  2020-02-27       Impact factor: 2.298

9.  Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity.

Authors:  Alberto Esquenazi; Ganesh Bavikatte; Daniel S Bandari; Wolfgang H Jost; Michael C Munin; Simon Fuk Tan Tang; Joan Largent; Aubrey Manack Adams; Aleksej Zuzek; Gerard E Francisco
Journal:  PM R       Date:  2021-01-11       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.